Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
The Readout Loud
00:00
Biotec's Checkmate Acquisition - Why the Glass Is Halfful
regeneran pharmacutical one of biotec's largest and most successful drug makers, announced its intention to purchase checkmate pharmaticals. This suggests that companies like regeneron are perceiving this sort of discontinuity in valuations and and are seeing bargains out there. But atam, i turn to you, as always, for a why the glass is half empty. Atam: There are some data suggesting a lot of companies might be in a similar position right at him!
Transcript
Play full episode
